Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,795 | -53,585 | -34,200 | -21,520 | -10,137 |
| Depreciation Amortization | 283 | 1,178 | 891 | 597 | 299 |
| Accounts payable and accrued liabilities | 712 | -201 | -194 | -286 | -124 |
| Other Working Capital | -2,964 | 1,549 | -1,351 | -1,063 | -1,701 |
| Other Operating Activity | 5,243 | 14,716 | 7,655 | 4,097 | 1,883 |
| Operating Cash Flow | $-13,521 | $-36,343 | $-27,199 | $-18,175 | $-9,780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -45 | -125 | -72 | -34 | -5 |
| Investing Cash Flow | $-45 | $-125 | $-72 | $-34 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -222 | N/A | N/A |
| Common Stock Issued | 14,807 | 110,422 | 62,161 | 40 | 305 |
| Other Financing Activity | 0 | -281 | 0 | 0 | 0 |
| Financing Cash Flow | $14,807 | $110,141 | $61,939 | $40 | $305 |
| Beginning Cash Position | 118,038 | 44,365 | 44,365 | 44,365 | 44,365 |
| End Cash Position | 119,279 | 118,038 | 79,033 | 26,196 | 34,885 |
| Net Cash Flow | $1,241 | $73,673 | $34,668 | $-18,169 | $-9,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,521 | -36,343 | -27,199 | -18,175 | -9,780 |
| Capital Expenditure | -45 | -125 | -72 | -34 | -5 |
| Free Cash Flow | -13,566 | -36,468 | -27,271 | -18,209 | -9,785 |